Dow Down 0.25% Nasdaq Down 0.14%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
13.69 0.66(4.60%) Sep 29, 4:00PM EDT
Prev Close:14.35
Open:14.16
Bid:13.11 x 100
Ask:14.77 x 300
1y Target Est:33.63
Beta:3.32
Earnings Date:Nov 6 - Nov 10 (Est.)
Day's Range:13.45 - 14.24
52wk Range:10.76 - 38.84
Volume:2,609,069
Avg Vol (3m):1,893,090
Market Cap:1.22B
P/E (ttm):N/A
EPS (ttm):-1.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CLDXDown 4.60%1.22B
DNDN236.25M
LLY70.02B
RHHBY250.73B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):491.92
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.32
Quarterly EPS Est (Sep-14) :-0.33
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback